CLINICAL_TRIALS
trial_result
· 2024-04-23
Clinical Trial Update: A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) [Phase 2]
Summary
Phase 2 trial of LY3471851 in adults with systemic lupus erythematosus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nektar Therapeutics | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2024-04-23